カテゴリー： QYResearch, 世界

世界の淋菌感染症治療市場 2019年

【英語タイトル】Global Neisseria Gonorrhoeae Infections Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X11919）・商品コード：DATA909X11919
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、淋菌感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他に、用途別には、クリニック、病院、その他にセグメント区分し、淋菌感染症治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・淋菌感染症治療の世界市場概要
・淋菌感染症治療の製造コスト構成分析
・淋菌感染症治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・淋菌感染症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・淋菌感染症治療のセグメント分析（種類別）
（クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）
・淋菌感染症治療のセグメント分析（用途別）
（クリニック、病院、その他）
・淋菌感染症治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Allergan Plc、BioDiem Ltd、Biolytics Pharma、Debiopharm International SA、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Merck & Co., Inc.、Paratek Pharmaceuticals, Inc.、Recce Pty Ltd、Redx Pharma Plc、Sarepta Therapeutics, Inc.、Sumitomo Dainippon Pharma Co., Ltd.、）
・淋菌感染症治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Neisseria Gonorrhoeae Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Neisseria Gonorrhoeae Infections Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neisseria Gonorrhoeae Infections Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neisseria Gonorrhoeae Infections Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neisseria Gonorrhoeae Infections Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Allergan Plc
BioDiem Ltd
Biolytics Pharma
Debiopharm International SA
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Merck & Co., Inc.
Paratek Pharmaceuticals, Inc.
Recce Pty Ltd
Redx Pharma Plc
Sarepta Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cribrostatin-6
Dalbavancin
Debio-1453
Gepotidacin Mesylate
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Neisseria Gonorrhoeae Infections Treatment
1.1 Definition of Neisseria Gonorrhoeae Infections Treatment
1.2 Neisseria Gonorrhoeae Infections Treatment Segment by Type
1.2.1 Global Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cribrostatin-6
1.2.3 Dalbavancin
1.2.4 Debio-1453
1.2.5 Gepotidacin Mesylate
1.2.6 Others
1.3 Neisseria Gonorrhoeae Infections Treatment Segment by Applications
1.3.1 Global Neisseria Gonorrhoeae Infections Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Neisseria Gonorrhoeae Infections Treatment Overall Market
1.4.1 Global Neisseria Gonorrhoeae Infections Treatment Revenue (2014-2025)
1.4.2 Global Neisseria Gonorrhoeae Infections Treatment Production (2014-2025)
1.4.3 North America Neisseria Gonorrhoeae Infections Treatment Status and Prospect (2014-2025)
1.4.4 Europe Neisseria Gonorrhoeae Infections Treatment Status and Prospect (2014-2025)
1.4.5 China Neisseria Gonorrhoeae Infections Treatment Status and Prospect (2014-2025)
1.4.6 Japan Neisseria Gonorrhoeae Infections Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Neisseria Gonorrhoeae Infections Treatment Status and Prospect (2014-2025)
1.4.8 India Neisseria Gonorrhoeae Infections Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neisseria Gonorrhoeae Infections Treatment
2.3 Manufacturing Process Analysis of Neisseria Gonorrhoeae Infections Treatment
2.4 Industry Chain Structure of Neisseria Gonorrhoeae Infections Treatment

3 Development and Manufacturing Plants Analysis of Neisseria Gonorrhoeae Infections Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Neisseria Gonorrhoeae Infections Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Neisseria Gonorrhoeae Infections Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Neisseria Gonorrhoeae Infections Treatment Production and Capacity Analysis
4.2 Neisseria Gonorrhoeae Infections Treatment Revenue Analysis
4.3 Neisseria Gonorrhoeae Infections Treatment Price Analysis
4.4 Market Concentration Degree

5 Neisseria Gonorrhoeae Infections Treatment Regional Market Analysis
5.1 Neisseria Gonorrhoeae Infections Treatment Production by Regions
5.1.1 Global Neisseria Gonorrhoeae Infections Treatment Production by Regions
5.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue by Regions
5.2 Neisseria Gonorrhoeae Infections Treatment Consumption by Regions
5.3 North America Neisseria Gonorrhoeae Infections Treatment Market Analysis
5.3.1 North America Neisseria Gonorrhoeae Infections Treatment Production
5.3.2 North America Neisseria Gonorrhoeae Infections Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Neisseria Gonorrhoeae Infections Treatment Import and Export
5.4 Europe Neisseria Gonorrhoeae Infections Treatment Market Analysis
5.4.1 Europe Neisseria Gonorrhoeae Infections Treatment Production
5.4.2 Europe Neisseria Gonorrhoeae Infections Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Neisseria Gonorrhoeae Infections Treatment Import and Export
5.5 China Neisseria Gonorrhoeae Infections Treatment Market Analysis
5.5.1 China Neisseria Gonorrhoeae Infections Treatment Production
5.5.2 China Neisseria Gonorrhoeae Infections Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Neisseria Gonorrhoeae Infections Treatment Import and Export
5.6 Japan Neisseria Gonorrhoeae Infections Treatment Market Analysis
5.6.1 Japan Neisseria Gonorrhoeae Infections Treatment Production
5.6.2 Japan Neisseria Gonorrhoeae Infections Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Neisseria Gonorrhoeae Infections Treatment Import and Export
5.7 Southeast Asia Neisseria Gonorrhoeae Infections Treatment Market Analysis
5.7.1 Southeast Asia Neisseria Gonorrhoeae Infections Treatment Production
5.7.2 Southeast Asia Neisseria Gonorrhoeae Infections Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Neisseria Gonorrhoeae Infections Treatment Import and Export
5.8 India Neisseria Gonorrhoeae Infections Treatment Market Analysis
5.8.1 India Neisseria Gonorrhoeae Infections Treatment Production
5.8.2 India Neisseria Gonorrhoeae Infections Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Neisseria Gonorrhoeae Infections Treatment Import and Export

6 Neisseria Gonorrhoeae Infections Treatment Segment Market Analysis (by Type)
6.1 Global Neisseria Gonorrhoeae Infections Treatment Production by Type
6.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue by Type
6.3 Neisseria Gonorrhoeae Infections Treatment Price by Type

7 Neisseria Gonorrhoeae Infections Treatment Segment Market Analysis (by Application)
7.1 Global Neisseria Gonorrhoeae Infections Treatment Consumption by Application
7.2 Global Neisseria Gonorrhoeae Infections Treatment Consumption Market Share by Application (2014-2019)

8 Neisseria Gonorrhoeae Infections Treatment Major Manufacturers Analysis
8.1 Allergan Plc
8.1.1 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.1.2 Allergan Plc Product Introduction, Application and Specification
8.1.3 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 BioDiem Ltd
8.2.1 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.2.2 BioDiem Ltd Product Introduction, Application and Specification
8.2.3 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Biolytics Pharma
8.3.1 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.3.2 Biolytics Pharma Product Introduction, Application and Specification
8.3.3 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Debiopharm International SA
8.4.1 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.4.2 Debiopharm International SA Product Introduction, Application and Specification
8.4.3 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.5.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
8.5.3 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 GlaxoSmithKline Plc
8.6.1 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.6.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.6.3 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Merck & Co., Inc.
8.7.1 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.7.2 Merck & Co., Inc. Product Introduction, Application and Specification
8.7.3 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Paratek Pharmaceuticals, Inc.
8.8.1 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.8.2 Paratek Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.8.3 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Recce Pty Ltd
8.9.1 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.9.2 Recce Pty Ltd Product Introduction, Application and Specification
8.9.3 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Redx Pharma Plc
8.10.1 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
8.10.2 Redx Pharma Plc Product Introduction, Application and Specification
8.10.3 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Sarepta Therapeutics, Inc.
8.12 Sumitomo Dainippon Pharma Co., Ltd.

9 Development Trend of Analysis of Neisseria Gonorrhoeae Infections Treatment Market
9.1 Global Neisseria Gonorrhoeae Infections Treatment Market Trend Analysis
9.1.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Neisseria Gonorrhoeae Infections Treatment Regional Market Trend
9.2.1 North America Neisseria Gonorrhoeae Infections Treatment Forecast 2019-2025
9.2.2 Europe Neisseria Gonorrhoeae Infections Treatment Forecast 2019-2025
9.2.3 China Neisseria Gonorrhoeae Infections Treatment Forecast 2019-2025
9.2.4 Japan Neisseria Gonorrhoeae Infections Treatment Forecast 2019-2025
9.2.5 Southeast Asia Neisseria Gonorrhoeae Infections Treatment Forecast 2019-2025
9.2.6 India Neisseria Gonorrhoeae Infections Treatment Forecast 2019-2025
9.3 Neisseria Gonorrhoeae Infections Treatment Market Trend (Product Type)
9.4 Neisseria Gonorrhoeae Infections Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Neisseria Gonorrhoeae Infections Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Neisseria Gonorrhoeae Infections Treatment
Table Global Neisseria Gonorrhoeae Infections Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Neisseria Gonorrhoeae Infections Treatment Production Market Share by Types in 2018
Figure Cribrostatin-6 Product Picture
Figure Dalbavancin Product Picture
Figure Debio-1453 Product Picture
Figure Gepotidacin Mesylate Product Picture
Figure Others Product Picture
Table Global Neisseria Gonorrhoeae Infections Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Neisseria Gonorrhoeae Infections Treatment Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Neisseria Gonorrhoeae Infections Treatment Revenue (Million USD) (2014-2025)
Figure Global Neisseria Gonorrhoeae Infections Treatment Production (K Pcs) (2014-2025)
Figure North America Neisseria Gonorrhoeae Infections Treatment Market Size (Million USD) (2014-2025)
Figure Europe Neisseria Gonorrhoeae Infections Treatment Market Size (Million USD) (2014-2025)
Figure China Neisseria Gonorrhoeae Infections Treatment Market Size (Million USD) (2014-2025)
Figure Japan Neisseria Gonorrhoeae Infections Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Neisseria Gonorrhoeae Infections Treatment Market Size (Million USD) (2014-2025)
Figure India Neisseria Gonorrhoeae Infections Treatment Market Size (Million USD) (2014-2025)
Table Neisseria Gonorrhoeae Infections Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neisseria Gonorrhoeae Infections Treatment in 2018
Figure Manufacturing Process Analysis of Neisseria Gonorrhoeae Infections Treatment
Figure Industry Chain Structure of Neisseria Gonorrhoeae Infections Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Neisseria Gonorrhoeae Infections Treatment Manufacturing Plants Distribution
Table Neisseria Gonorrhoeae Infections Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Neisseria Gonorrhoeae Infections Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Neisseria Gonorrhoeae Infections Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Neisseria Gonorrhoeae Infections Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Neisseria Gonorrhoeae Infections Treatment Production Share by Manufacturers in 2018
Table Neisseria Gonorrhoeae Infections Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Neisseria Gonorrhoeae Infections Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Neisseria Gonorrhoeae Infections Treatment Revenue Share by Manufacturers in 2018
Table Neisseria Gonorrhoeae Infections Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Neisseria Gonorrhoeae Infections Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Neisseria Gonorrhoeae Infections Treatment Production Market Share by Regions 2014-2019
Figure Global Neisseria Gonorrhoeae Infections Treatment Production Market Share by Regions in 2018
Table Global Neisseria Gonorrhoeae Infections Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Regions 2014-2019
Figure Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Regions in 2018
Table Global Neisseria Gonorrhoeae Infections Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Neisseria Gonorrhoeae Infections Treatment Consumption Market Share by Regions 2014-2019
Figure North America Neisseria Gonorrhoeae Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Neisseria Gonorrhoeae Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Neisseria Gonorrhoeae Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Neisseria Gonorrhoeae Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure China Neisseria Gonorrhoeae Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Neisseria Gonorrhoeae Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Neisseria Gonorrhoeae Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Neisseria Gonorrhoeae Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Neisseria Gonorrhoeae Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Neisseria Gonorrhoeae Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure India Neisseria Gonorrhoeae Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Neisseria Gonorrhoeae Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2014-2019)
Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure Allergan Plc Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
Table Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
Table Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production Market Share (2014-2019)
Figure Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Revenue Market Share (2014-2019)
Table Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Main Business and Markets Served
Table Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Table Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
Figure Global Neisseria Gonorrhoeae Infections Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Neisseria Gonorrhoeae Infections Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Neisseria Gonorrhoeae Infections Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Neisseria Gonorrhoeae Infections Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Neisseria Gonorrhoeae Infections Treatment by Application (2019-2025)
Table Neisseria Gonorrhoeae Infections Treatment Distributors List
Table Neisseria Gonorrhoeae Infections Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Allergan Plc、BioDiem Ltd、Biolytics Pharma、Debiopharm International SA、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Merck & Co., Inc.、Paratek Pharmaceuticals, Inc.、Recce Pty Ltd、Redx Pharma Plc、Sarepta Therapeutics, Inc.、Sumitomo Dainippon Pharma Co., Ltd.、

★調査レポート[世界の淋菌感染症治療市場 2019年] (コード：DATA909X11919)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の淋菌感染症治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の髄膜炎菌感染症治療薬市場 2019年
    DATA909X11920 / QYResearch / 2019年11月20日 / ※本調査レポートは、髄膜炎菌感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、MGBBP-3、NCL-195、TP-10、その他に、用途別には、病院、クリニック、その他にセグメント区分し、髄膜炎菌感染症治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・髄膜炎菌感染症治療薬の世界市場概要 ・髄膜炎菌感染症治療薬の製造コスト構成分析 ・髄膜炎菌感染症治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・髄膜炎菌感染症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・髄膜炎菌感染症治療薬のセグメント分析（種類別） （MGBBP-3、NCL-195、TP-10、その他）...The global Neisseria meningitidis Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neisseria meningitidis Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neisseria meningitidis Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Neisseria meningitidis Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の人工関節感染症治療市場 2019年
    DATA909X13818 / QYResearch / 2019年11月20日 / ※本調査レポートは、人工関節感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他に、用途別には、病院、診療所、その他にセグメント区分し、人工関節感染症治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・人工関節感染症治療の世界市場概要 ・人工関節感染症治療の製造コスト構成分析 ・人工関節感染症治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・人工関節感染症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・人工関節感染症治療のセグメント分析（種類別） （フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）...The global Prosthetic Joint Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Prosthetic Joint Infections Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prosthetic Joint Infections Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Prosthetic Joint Infections Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のライノウイルス感染薬市場 2019年
    DATA909X14407 / QYResearch / 2019年11月20日 / ※本調査レポートは、ライノウイルス感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ライノウイルス感染薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ライノウイルス感染薬の世界市場概要 ・ライノウイルス感染薬の製造コスト構成分析 ・ライノウイルス感染薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ライノウイルス感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ライノウイルス感染薬のセグメント分析（種類別） （塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他）...The global Rhinovirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rhinovirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rhinovirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rhinovirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のロタウイルス感染症治療薬市場 2019年
    DATA909X14590 / QYResearch / 2019年11月20日 / ※本調査レポートは、ロタウイルス感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、農業、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ロタウイルス感染症治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ロタウイルス感染症治療薬の世界市場概要 ・ロタウイルス感染症治療薬の製造コスト構成分析 ・ロタウイルス感染症治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ロタウイルス感染症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ロタウイルス感染症治療薬のセグメント分析（種類別） （農業、その他）...The global Rotavirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rotavirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rotavirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rotavirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の耐性緑膿菌感染症薬市場 2019年
    DATA909X14315 / QYResearch / 2019年11月20日 / ※本調査レポートは、耐性緑膿菌感染症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、半合成ペニシリン、セファロスポリン、ラクタム薬、その他に、用途別には、病院、診療所、在宅ケアにセグメント区分し、耐性緑膿菌感染症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・耐性緑膿菌感染症薬の世界市場概要 ・耐性緑膿菌感染症薬の製造コスト構成分析 ・耐性緑膿菌感染症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・耐性緑膿菌感染症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・耐性緑膿菌感染症薬のセグメント分析（種類別） （半合成ペニシリン、セファロスポリン、ラクタム薬、その他）...The global Resistant Pseudomonas Aeruginosa Infections Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Resistant Pseudomonas Aeruginosa Infections Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Resistant Pseudomonas Aeruginosa Infections Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Resistant Pseudomonas Aeruginosa Infections Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のインフルエンザAウイルス、H3N2サブタイプ感染薬市場 2019年
    DATA909X09790 / QYResearch / 2019年11月20日 / ※本調査レポートは、インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、NEO-8877、NP-025、NSC-61610、NVINF-1、その他に、用途別には、クリニック、病院、その他にセグメント区分し、インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場概要 ・インフルエンザAウイルス、H3N2サブタイプ感染薬の製造コスト構成分析 ・インフルエンザAウイルス、H3N2サブタイプ感染薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・インフルエンザAウイルス、H3N2サブタイプ感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・インフルエンザAウイルス、H3N2サブタイプ感染薬のセグメント分析（種類別） （NEO-8877、NP-025、NSC-61610、NVINF-1、その他）...The global Influenza A Virus, H3N2 Subtype Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Influenza A Virus, H3N2 Subtype Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza A Virus, H3N2 Subtype Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Influenza A Virus, H3N2 Subtype Infections Drug in...

    • ◆H&Iグローバルリサーチのお客様（例）◆